The wide dissemination of hip dysplasia among large dogs has led, over the years, to a variety of control programmes. Until now, the diagnostic evaluation of radiographs has been essential for any successful combat against hip dysplasia. Judging procedures differ, although generally within narrow limits. On the continent, the recommendations of the Federation Cynologique Internationale are followed to a large extent. Hip dysplasia has polygenic hereditary traits. Besides the influences of the genes, there are also environmental factors that play a role in the variability of the hip status. Breed schemes have, so far, been based on selection and the partial or total exclusion of affected dogs from breeding. The system applied to German shepherd dogs in West Germany in the last 20 years has proved successful without imposing strict measures.
MEBITALJOSHRNAL (921 Ekbom (1947) using " gynergen "1 reported results similar to our own. It has been our impression that gastro-intestinal side-effects were less marked with migril than with other preparations, but we have no statistically valid evidence to support this view.We are unable to throw any light on the aetiology of this condition. We see no reason why it should be attributed to histamine allergy and it is also difficult to relate it to migraine. In our cases a family history of migraine was rarely obtained, and this would be unexpected if this condition was indeed a variant of the migraine syndrome in which a positive family history is the rule rather than the exception. The age and sex distribution is also somewhat different from that of migraine, many of our patients having had their first symptoms in their forties. Though these are only two facets of the clinical picture, they may be of possible significance in distinguishing this syndrome from migraine. Summary Twenty-eight cases of periodic migrainous neuralgia are reviewed. The cermical picture is described. The average time which elapsed between the onset of symptoms and accurate I Known in Great Britain as " femergen." diagnosis was 6.5 years. Our experiences of treatment using prophylactic migril in 20 patients are discussed. In 14 the response was satisfactory and in six relief was only slight. Two of these patients showed further improvement on prophylactic ergotamine injections. Three patients who failed to respond to oral ergotamine or relapsed responded to methysergide. A plea is made for early diagnosis in this eminently treatable condition.We are grateful to Dr. Henry Miller for allowing us to review a number of patients who were under his care.
SUMMARY The significance of a positive thyroid complement-fixation (c.f.) test in thyrotoxicosis has been investigated by studying the correlation between various features of the disease in 468 patients. A significant correlation was found between the positivity of the c.f. test and (1) the degree of lymphocytic infiltration in the gland; (2) incidence of postoperative hypothyroidism; (3) size of the goitre; (4) previous treatment with radioiodine, and (5) a family history of thyroid disease. No correlation was found between the results of the test and the incidence of reactions to antithyroid drugs. The results suggest that thyrotoxic patients with positive c.f. tests should be treated initially with antithyroid drugs unless there is a definite indication for surgery.
Testamos em 25 cães a aplicação do isobutil-2-cianoacrilato Grupo I=13 e n-butil-a -cianoacrilato Grupo II=12 para anastomose intestinal látero-lateral. As anastomoses foram avaliadas aos 4, 14 e 28 dias de p.o. Observamos macroscópicamente aderência entre o epiploo e a ferida cirúrgica da parede abdominal em ambos os grupos. Comparando os Grupos I e II através o teste t não pareado, estatisticamente não apresentaram diferença significativa (p=0,3624). Ao exame histológico notamos reação inflamatória, granuloma e no seu interior presença do adesivo.
Isobutyl-2-cyanoacrylate (Group I) and n-butyl-a -cyanoacrylate (Group II) were tested in two groups of dogs: Group I=13 dogs and Group II=12 dogs that had intestinal laterolateral anastomosis.The anastomosis were avaluated on days: 4, 14 and 28 after surgery. Adhesions between omentum and the surgical wall wound were grossly observed in both groups. Regarding the presence of adhesions comparing the two groups with unpaired t test, the difference between Group I and II is not significant (p=0,3624). Histology revealed inflammation and granuloma on the anastomosis with the adhesive inside of it both with isobutyl-2-cyanoacrylate and n-butyl-a -cyanoacrylate
Testou-se em 25 cães a aplicação do isobutil-2-cianoacrilato (Grupo I) e n-butil-a -cianoacrilato (Grupo II) para anastomose intestinal látero-lateral. As anastomoses foram avaliadas aos quatro, 14 e 28 dias de p.o. Observou-se macroscópicamente aderência entre o epiploo e a ferida cirúrgica da parede abdominal em ambos os grupos. Comparando os Grupos I e II através o teste t não pareado, estatisticamente não apresentaram diferença significativa (p=0,3624). Ao exame histológico notou-se reação inflamatória, granuloma e no seu interior presença do adesivo
Isobutyl-2-cyanoacrylate (Group I) and n-butyl-a -cyanoacriylate (Group II) were tested in two groups of dogs: Group I=13 dogs and Group II=12 dogs that had intestinal laterolateral anastomosis.The anastomosis were avaluated on days: 4, 14 and 28 after surgery. Adhesions between omentum and the surgical wall wound were grossly in both groups. Regarding the presence of adhesions comparing the two groups with unpaired t test, the difference between the Group I and II is not significant (p=0,3624). Histology revealed inflammation and granuloma on the anastomosis with the adhesive inside of it both with isobutyl-2-cyanoacrylate and n-butyl-a -cyanoacriylat
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.